Neuroscience News

Neuroradiologist Raag Airan and his lab have found a non-invasive, drug-free method to help clean the brain, reduce inflammation, and treat disease—and with Knight Initiative for Brain Resilience support, they plan to test it in people soon.

The Knight Initiative’s Fall Symposium featured researchers building new molecular atlases of the brain alongside new updates on neurodegenerative disease and what might be done about it.

Research from Knight Initiative Director Tony Wyss-Coray's lab show that an Alzheimer's hallmark—myriad oily droplets in brain cells called microglia—may help connect several of the disorder’s better known but not well understood features.

Neurons are built to last, but with age, bad things can happen to them. Wu Tsai Neuro affiliate Katrin Andreasson's work shows a lot of it is triggered by what’s happening to immune cells outside of the brain.

A new study led by Wu Tsai Neuro Faculty Scholar Laura Gwilliams maps how we simultaneously process different words.

In which we discuss how bad social isolation is for our brains with neuroscientist and author Ben Rein

Organizers of the Wu Tsai Neurosciences Institute’s 12th annual symposium share exciting new discoveries from the frontiers of the “gut-brain axis.”

Amyloid plaques have long been the focus of Alzheimer’s therapies. But Wu Tsai Neuro's Emmanuel Mignot and others are focusing on the stringy tangles of a protein called tau, the unsung second hallmark of Alzheimer’s.

The genetic variant APOE4, carried by one-fifth of the world’s people, substantially boosts Alzheimer’s risk. But scientists have been puzzled about how to reverse that risk: punch up the gene variant’s potency, or smack it down? Now we know, thanks to research funded by the Knight Initiative for Brain Resilience.

Researchers from around the university will collaborate to deepen our understanding of the brain.

Stanford's Office of Postdoctoral Affairs has named Hulya Torun one of this year's Postdoc Champions

A new study finds links between two popular models of the disease—and the results could change how researchers think about treatment.

Knight Initiative researchers are uncovering the fine points of how our brains learn to move. In the long run, their findings could help devise better treatments for Parkinson's disease.

In this episode, we talk with neuroscientist, musician and author Daniel Levitin about his new book on the neuroscience of music and how it is being used to help heal disorders from Parkinson's to chronic pain

A study of killifish reveals how protein dysfunction develops in vertebrate brain cells, a key driver of aging – shedding light on cognitive decline and dise

Stanford researchers reviewed over 400 therapy evaluations and discovered a crucial mismatch: Mouse studies test disease prevention, while human trials test treatment of existing disease.